No Increased Risk of Lung Infections Among Infants Using Popular Anti-Reflux Medicines
September 18, 2018
September 18, 2018
DUNEDIN, New Zealand, Sept. 18 -- The University of Otago issued the following news release:
New University of Otago research shows infants using popular anti-reflux medicines like omeprazole are not at increased risk of pneumonia or other lower respiratory tract infections, contrary to findings from other international studies.
Lead researcher, Mei-Ling Blank from the Department of Preventive and Social Medicine says use of the drugs - proton pump inhibitors (PPIs) - b . . .
New University of Otago research shows infants using popular anti-reflux medicines like omeprazole are not at increased risk of pneumonia or other lower respiratory tract infections, contrary to findings from other international studies.
Lead researcher, Mei-Ling Blank from the Department of Preventive and Social Medicine says use of the drugs - proton pump inhibitors (PPIs) - b . . .